Total Payments
$844,711
2024 Payments
$161,331
Companies
44
Transactions
1,749
Medicare Patients
1,602
Medicare Billing
$1.2M

Payment Breakdown by Category

Other$553,638 (65.5%)
Consulting$192,912 (22.8%)
Travel$44,739 (5.3%)
Food & Beverage$35,157 (4.2%)
Research$18,048 (2.1%)
Education$217.51 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $384,222 196 45.5%
Consulting Fee $192,912 65 22.8%
Honoraria $169,416 77 20.1%
Travel and Lodging $44,739 154 5.3%
Food and Beverage $35,157 1,234 4.2%
Unspecified $18,048 12 2.1%
Education $217.51 11 0.0%

Payments by Type

General
$826,664
1,737 transactions
Research
$18,048
12 transactions

Top Paying Companies

Company Total Records Latest Year
CSL Behring $221,364 387 $0 (2024)
Pharming Healthcare, Inc. $146,178 164 $0 (2024)
Shire North American Group Inc $128,450 182 $0 (2019)
Takeda Pharmaceuticals U.S.A., Inc. $107,519 146 $0 (2024)
GlaxoSmithKline, LLC. $88,903 186 $0 (2024)
BioCryst US Sales Co., LLC $55,376 51 $0 (2024)
Blueprint Medicines Corporation $25,286 50 $0 (2024)
BioCryst Pharmaceuticals, Inc. $22,322 29 $0 (2023)
Boehringer Ingelheim Pharmaceuticals, Inc. $20,674 12 $0 (2021)
AstraZeneca Pharmaceuticals LP $8,012 155 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $161,331 296 CSL Behring ($75,570)
2023 $139,455 271 Takeda Pharmaceuticals U.S.A., Inc. ($40,824)
2022 $88,627 232 CSL Behring ($22,369)
2021 $100,541 200 CSL Behring ($29,963)
2020 $84,968 173 CSL Behring ($22,601)
2019 $94,988 216 Shire North American Group Inc ($40,183)
2018 $88,062 179 Shire North American Group Inc ($49,720)
2017 $86,740 182 Shire North American Group Inc ($38,547)

All Payment Transactions

1,749 individual payment records from CMS Open Payments — Page 1 of 70

Date Company Product Nature Form Amount Type
12/20/2024 CSL Behring Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $3,000.00 General
12/19/2024 CSL Behring Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program In-kind items and services $1,329.50 General
12/19/2024 CSL Behring Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program In-kind items and services $354.80 General
12/19/2024 CSL Behring Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program In-kind items and services $147.50 General
12/17/2024 CSL Behring Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program In-kind items and services $2,645.10 General
12/17/2024 CSL Behring Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program In-kind items and services $629.30 General
12/17/2024 CSL Behring Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program In-kind items and services $566.40 General
12/17/2024 CSL Behring Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program In-kind items and services $426.10 General
12/17/2024 CSL Behring Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program In-kind items and services $415.30 General
12/17/2024 CSL Behring Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program In-kind items and services $147.50 General
12/17/2024 AstraZeneca Pharmaceuticals LP TEZSPIRE (Biological) Food and Beverage In-kind items and services $13.08 General
Category: Respiratory
12/13/2024 CSL Behring Haegarda (Biological) Food and Beverage In-kind items and services $25.31 General
Category: Immunology
12/12/2024 CSL Behring Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $5,250.00 General
12/12/2024 CSL Behring Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,500.00 General
12/12/2024 GlaxoSmithKline, LLC. NUCALA (Biological) Food and Beverage In-kind items and services $18.97 General
Category: IMMUNOLOGY
12/10/2024 Optinose US, Inc. Xhance (Drug) Food and Beverage In-kind items and services $24.95 General
Category: Otolaryngology (Ear, Nose, Throat)
12/09/2024 PFIZER INC. OCTAGAM IMMUNE GLOBULIN (HUMAN) (Drug), PANZYGA, CUTAQUIG Food and Beverage In-kind items and services $27.87 General
Category: IMMUNOLOGY
12/09/2024 Regeneron Healthcare Solutions, Inc. DUPIXENT (Biological) Food and Beverage In-kind items and services $13.79 General
Category: INFLAMMATION AND IMMUNOLOGY
12/09/2024 CSL Behring Haegarda (Biological) Food and Beverage In-kind items and services $8.58 General
Category: Immunology
12/06/2024 Blueprint Medicines Corporation AYVAKIT (Drug) Food and Beverage Cash or cash equivalent $33.96 General
Category: Oncology / Rare Diseases
12/04/2024 AstraZeneca Pharmaceuticals LP FASENRA (Biological) Food and Beverage In-kind items and services $21.94 General
Category: Respiratory
12/03/2024 Genentech USA, Inc. Xolair (Biological) Food and Beverage In-kind items and services $19.36 General
Category: Immunology
12/02/2024 Blueprint Medicines Corporation AYVAKIT (Drug) Honoraria Cash or cash equivalent $868.00 General
Category: Oncology / Rare Diseases
12/02/2024 Genentech USA, Inc. Xolair (Biological) Food and Beverage In-kind items and services $25.06 General
Category: Immunology
12/02/2024 BioCryst US Sales Co., LLC ORLADEYO (Drug) Food and Beverage In-kind items and services $21.04 General
Category: Immunology

Research Studies & Clinical Trials

Study Name Company Amount Records
COPD pragmatic randomised clinical trial Boehringer Ingelheim Pharmaceuticals, Inc. $15,000 1
An Open-label, Randomized, Actual Use Study of Dupilumab Auto-injector Device in Patients With Atopic Dermatitis Regeneron Pharmaceuticals, Inc. $2,148 3
An Open-label Study to Evaluate the Long-term Safety and Efficacy of CSL312 (Garadacimab) in the Prophylactic Treatment of Hereditary Angioedema CSL Behring $491.16 2
A RANDOMIZED, DOUBLE-BLIND, PARALLEL GROUP, MULTICENTER, STRATIFIED ST GlaxoSmithKline, LLC. $408.14 6

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 15 476 12,309 $604,771 $312,042
2022 13 388 12,054 $454,250 $292,842
2021 11 303 10,450 $408,674 $266,492
2020 15 435 13,063 $485,515 $311,608
Total Patients
1,602
Total Services
47,876
Medicare Billing
$1.2M
Procedure Codes
54

All Medicare Procedures & Services

54 procedure records from CMS Medicare Utilization — Page 1 of 3

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
J2357 Injection, omalizumab, 5 mg Office 2023 21 8,970 $509,130 $269,987 53.0%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 123 202 $26,462 $17,108 64.7%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 45 45 $8,505 $5,078 59.7%
96372 Injection of drug or substance under skin or into muscle Office 2023 34 399 $10,374 $3,750 36.1%
95004 Test for allergy using allergenic extract Office 2023 24 1,180 $9,440 $3,194 33.8%
95044 Test for allergy using skin patch Office 2023 14 849 $12,735 $2,942 23.1%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 15 18 $3,564 $2,288 64.2%
94010 Test to measure expiratory airflow and volume Office 2023 49 79 $6,636 $1,447 21.8%
95165 Professional service for preparation and provision of 1 or more antigens Office 2023 15 144 $2,304 $1,383 60.0%
99443 Telephone medical discussion with physician, 21-30 minutes Office 2023 18 20 $2,620 $1,291 49.3%
95117 Professional service for multiple injections of allergen Office 2023 26 195 $7,917 $1,278 16.1%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 17 19 $1,805 $1,261 69.9%
95024 Test for allergy using allergenic extract injected into skin Office 2023 11 96 $1,536 $537.41 35.0%
95012 Test to measure the level of nitric oxide gas Office 2023 24 29 $783.00 $377.87 48.3%
96160 Administration and interpretation of patient-focused health risk assessment Office 2023 40 64 $960.00 $119.07 12.4%
J2357 Injection, omalizumab, 5 mg Office 2022 14 8,627 $370,961 $256,997 69.3%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 98 132 $17,292 $11,914 68.9%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 58 58 $10,962 $6,704 61.2%
95004 Test for allergy using allergenic extract Office 2022 34 1,512 $12,096 $4,457 36.8%
96372 Injection of drug or substance under skin or into muscle Office 2022 25 367 $9,542 $3,756 39.4%
95044 Test for allergy using skin patch Office 2022 13 715 $10,725 $2,375 22.1%
95117 Professional service for multiple injections of allergen Office 2022 16 198 $9,471 $1,560 16.5%
95165 Professional service for preparation and provision of 1 or more antigens Office 2022 14 121 $1,936 $1,327 68.5%
99443 Telephone medical discussion with physician, 21-30 minutes Office 2022 15 16 $2,096 $1,232 58.8%
94010 Test to measure expiratory airflow and volume Office 2022 42 61 $5,124 $1,167 22.8%

About Dr. John Anderson, M.D

Dr. John Anderson, M.D is a Student in an Organized Health Care Education/Training Program healthcare provider based in Homewood, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/03/2007. The National Provider Identifier (NPI) number assigned to this provider is 1154543452.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Anderson, M.D has received a total of $844,711 in payments from pharmaceutical and medical device companies, with $161,331 received in 2024. These payments were reported across 1,749 transactions from 44 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($384,222).

As a Medicare-enrolled provider, Anderson has provided services to 1,602 Medicare beneficiaries, totaling 47,876 services with total Medicare billing of $1.2M. Data is available for 4 years (2020–2023), covering 54 distinct procedure/service records.

Practice Information

Products in Payments

  • RUCONEST (Biological) $139,725
  • CINRYZE (Drug) $138,434
  • Haegarda (Biological) $98,830
  • NUCALA (Biological) $85,869
  • TAKHZYRO (Biological) $64,429
  • ORLADEYO (Drug) $36,224
  • Orladeyo (Drug) $23,191
  • AYVAKIT (Drug) $20,222
  • Hizentra (Biological) $13,054
  • Privigen (Biological) $10,654
  • JOENJA (Drug) $6,421
  • FIRAZYR (Drug) $5,401
  • AIRSUPRA (Drug) $5,255
  • CINQAIR (Drug) $4,583
  • DUPIXENT DUPILUMAB INJECTION (Biological) $2,213
  • NITYR (Drug) $1,851
  • SPIRIVA RESPIMAT (Drug) $1,576
  • DUPIXENT (Biological) $1,390
  • TRELEGY ELLIPTA (Drug) $937.87
  • Xolair (Biological) $926.70

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Student in an Organized Health Care Education/Training Program Doctors in Homewood